← Back to Search

PARTNER Intervention for HIV Prevention (PARTNER Trial)

N/A
Waitlist Available
Led By Tyrel J Starks, PhD
Research Sponsored by Hunter College of City University of New York
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 to 29 years of age (inclusive)
Must be in a main partner relationship with another male (duration ≥ 1 months)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 month
Awards & highlights

PARTNER Trial Summary

This trial looks at whether a 4-session motivational intervention can help YMSM in relationships to take PrEP, reduce HIV transmission risk behavior, and associated drug use.

Who is the study for?
This trial is for young men who have sex with men (YMSM), aged 18-29, living in the NYC area. They must be HIV-negative, speak English, and be in a relationship for at least a month. Candidates should meet CDC criteria for PrEP use due to recent risky sexual behavior or substance use.Check my eligibility
What is being tested?
The PARTNER intervention is being tested; it's a short program using motivational interviewing over four sessions aimed at increasing uptake and adherence to PrEP, reducing HIV risk behaviors and drug use among YMSM.See study design
What are the potential side effects?
Since this trial focuses on education and behavioral interventions rather than medication, there are no direct medical side effects. However, participants may experience emotional discomfort discussing personal topics.

PARTNER Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 29 years old.
Select...
I have been in a relationship with another man for at least 1 month.
Select...
I have used substances like marijuana, cocaine, or MDMA in the last 30 days.

PARTNER Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of HIV transmission risk events
Number of drug use instances
Positive drug assays
+2 more
Secondary outcome measures
Effectiveness of intervention implementation
Pre-Exposure Prophylaxis (PrEP) adherence

PARTNER Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: PARTNER InterventionExperimental Treatment1 Intervention
This intervention is a four-session intervention designed to increase PrEP uptake, increase PrEP adherence, and reduce drug use and HIV transmission risk behaviors of individuals in relationships.
Group II: Education InterventionActive Control1 Intervention
This intervention is a four-session intervention that discussed drug use and its effect on physiological social functioning.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
PARTNER
2018
N/A
~200

Find a Location

Who is running the clinical trial?

Hunter College of City University of New YorkLead Sponsor
38 Previous Clinical Trials
8,686 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,492 Previous Clinical Trials
2,623,184 Total Patients Enrolled
Tyrel J Starks, PhDPrincipal InvestigatorHunter College of City University of New York
4 Previous Clinical Trials
500 Total Patients Enrolled

Media Library

HIV/AIDS Research Study Groups: PARTNER Intervention, Education Intervention
~27 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top